These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 19589772)
1. New drugs: golimumab, besifloxacin hydrochloride, and artemether/lumefantrine. Hussar DA J Am Pharm Assoc (2003); 2009; 49(4):570-4. PubMed ID: 19589772 [No Abstract] [Full Text] [Related]
2. Artemether-lumefantrine (Coartem) for treatment of malaria. Med Lett Drugs Ther; 2009 Sep; 51(1321):75-6. PubMed ID: 19763049 [No Abstract] [Full Text] [Related]
3. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil. Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806 [TBL] [Abstract][Full Text] [Related]
4. First artemisinin-based antimalarial combination approved for U.S. market. Thompson CA Am J Health Syst Pharm; 2009 May; 66(10):880. PubMed ID: 19420302 [No Abstract] [Full Text] [Related]
5. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Mulenga M; VangGeertruyden JP; Mwananyanda L; Chalwe V; Moerman F; Chilengi R; Van Overmeir C; Dujardin JC; D'Alessandro U Malar J; 2006 Aug; 5():73. PubMed ID: 16923176 [TBL] [Abstract][Full Text] [Related]
6. Alternative form of artemether-lumefantrine for infants. Teklehaimanot A; Teklehaimanot HD Lancet; 2008 Nov; 372(9652):1786-7. PubMed ID: 18926568 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Abdulla S; Sagara I; Borrmann S; D'Alessandro U; González R; Hamel M; Ogutu B; Mårtensson A; Lyimo J; Maiga H; Sasi P; Nahum A; Bassat Q; Juma E; Otieno L; Björkman A; Beck HP; Andriano K; Cousin M; Lefèvre G; Ubben D; Premji Z Lancet; 2008 Nov; 372(9652):1819-27. PubMed ID: 18926569 [TBL] [Abstract][Full Text] [Related]
8. Malaria management-progress made and challenges still to face. Ogutu BR Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S1. PubMed ID: 19818168 [No Abstract] [Full Text] [Related]
10. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228 [TBL] [Abstract][Full Text] [Related]
11. Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children. Adjei GO; Goka BQ; Binka F; Kurtzhals JA Expert Rev Anti Infect Ther; 2009 Aug; 7(6):669-81. PubMed ID: 19681693 [TBL] [Abstract][Full Text] [Related]
12. A simple dose regimen of artesunate and amodiaquine based on age or body weight range for uncomplicated falciparum malaria in children: comparison of therapeutic efficacy with standard dose regimen of artesunate and amodiaquine and artemether-lumefantrine. Gbotosho GO; Sowunmi A; Okuboyejo TM; Happi CT; Folarin OO; Adewoye EO Am J Ther; 2012 Jul; 19(4):e122-31. PubMed ID: 21519221 [TBL] [Abstract][Full Text] [Related]
13. Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire. Toure OA; Kouame MG; Didier YJ; Berenger AA; Djerea K; Genevieve GO; Penali LK Trop Med Int Health; 2011 Mar; 16(3):290-7. PubMed ID: 21214690 [TBL] [Abstract][Full Text] [Related]
14. Artemether-lumefantrine: an option for malaria. Stover KR; King ST; Robinson J Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial. Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Björkman A; Mårtensson A Clin Infect Dis; 2011 Apr; 52(7):873-82. PubMed ID: 21427394 [TBL] [Abstract][Full Text] [Related]
16. Coartem(®): a decade of patient-centric malaria management. Hamed K; Grueninger H Expert Rev Anti Infect Ther; 2012 Jun; 10(6):645-59. PubMed ID: 22554131 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O Malar J; 2007 Jun; 6():80. PubMed ID: 17570848 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Makanga M; Premji Z; Falade C; Karbwang J; Mueller EA; Andriano K; Hunt P; De Palacios PI Am J Trop Med Hyg; 2006 Jun; 74(6):991-8. PubMed ID: 16760509 [TBL] [Abstract][Full Text] [Related]
19. New Drugs2010, PART 1. Hussar DA Nursing; 2010 Feb; 40(2):36-45; quiz 45-7. PubMed ID: 20083979 [No Abstract] [Full Text] [Related]
20. Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia. Sutanto I; Suprianto S; Widiaty A; Rukmiyati ; Ruckert P; von Bethmann A; de Monbrison F; Picot S; Laihad F; Baird JK Acta Med Indones; 2012 Jul; 44(3):187-92. PubMed ID: 22983072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]